Generic · Extended-release tablet · Updated Nov 11, 2026
Lamotrigine 25 mg (24 hr) extended-release tablet price what pharmacies pay, and what you should
Is my price fair?
Check the price you were quoted
Type what the pharmacy asked for lamotrigine 25 mg (24 hr) extended-release tablet and see the markup over what they pay.
A benchmark from public data, not a price offer or medical advice. Prices vary by pharmacy, insurance and discount programs.
Lamotrigine 25 mg (24 hr) price history
What pharmacies pay for 30 tablets, weekly- Now
- $10.84
- 52-week low
- $7.26
- 52-week high
- $12.50
- A year ago
- $12.45
Why the price changed
| Effective | Before | After | Change | Reason |
|---|---|---|---|---|
| Oct 21, 2026 | $0.2751 | $0.3615 | +31.4% | pharmacies' invoice prices changed (survey) |
| Sep 23, 2026 | $0.2540 | $0.2751 | +8.3% | pharmacies' invoice prices changed (survey) |
| Aug 19, 2026 | $0.2421 | $0.2540 | +4.9% | pharmacies' invoice prices changed (survey) |
| Jul 22, 2026 | $0.2994 | $0.2421 | -19.1% | pharmacies' invoice prices changed (survey) |
| Jun 17, 2026 | $0.3619 | $0.2994 | -17.3% | pharmacies' invoice prices changed (survey) |
| May 20, 2026 | $0.4168 | $0.3619 | -13.2% | pharmacies' invoice prices changed (survey) |
| Apr 22, 2026 | $0.3711 | $0.4168 | +12.3% | pharmacies' invoice prices changed (survey) |
| Mar 18, 2026 | $0.3246 | $0.3711 | +14.3% | pharmacies' invoice prices changed (survey) |
Prices per tablet. Reasons are the ones the national survey gives: a survey rate change comes from pharmacies' own invoices; a published price change follows the maker's list price.
What people paid for lamotrigine 25 mg (24 hr) extended-release tablet
What did your pharmacy charge? It takes 30 seconds, it's anonymous - and it shows everyone which pharmacies are fair.
Supply status: shortages & recalls
Shortages
- Lamotrigine, Tablet, Extended Release, 100 mg (NDC 49884-563-11)Discontinuation of the manufacture of the drug
- Lamotrigine, Tablet, Extended Release, 25 mg (NDC 49884-561-11)Discontinuation of the manufacture of the drug
- Lamotrigine, Tablet, Extended Release, 250 mg (NDC 49884-604-11)Discontinuation of the manufacture of the drug
- Lamotrigine, Tablet, Extended Release, 300 mg (NDC 49884-605-11)Discontinuation of the manufacture of the drug
- Lamotrigine, Tablet, Extended Release, 50 mg (NDC 49884-562-11)Discontinuation of the manufacture of the drug
- Lamotrigine, Tablet, Extended Release, 200 mg (NDC 49884-564-11)Discontinuation of the manufacture of the drug
In a shortage, ask your pharmacist whether another strength, form or maker is in stock, and how much notice they need. What to do in a drug shortage.
Recalls
Showing the 6 most relevant of 13 - all recalls.
A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.
Every manufacturer and package code
7 companies sell lamotrigine 25 mg (24 hr) extended-release tablet under 9 package codes (NDCs). Pharmacies pay the same per tablet whichever maker they buy from - the national average is set for the generic as a group.
| Maker | Package codes | Per unit |
|---|---|---|
| Amneal Pharmaceuticals LLC | 65162-949-03 | $0.3615 |
| Camber Pharmaceuticals Inc | 31722-240-30 | $0.3615 |
| Dr.Reddy's Laboratories Limited | 55111-717-30 | $0.3615 |
| NorthStar Rx LLC | 16714-623-01 | $0.3615 |
| Torrent Pharmaceuticals Limited | 13668-339-30 | $0.3615 |
| Zydus Pharmaceuticals USA Inc. | 68382-979-06 | $0.3615 |
| Bryant Ranch Prepack | 71335-1469-1 | - |
All 9 package codes
2 older package codes are still priced but no longer in the current FDA listing.
A dash means no weekly price for that maker's packages. Which maker your pharmacy stocks usually doesn't change what you pay, but you can ask.
The brand costs 39x more
Make sure your prescription is filled with the generic unless your prescriber wrote "brand medically necessary".
Questions to ask your pharmacist
- "Am I being charged for the generic or the brand?" The brand costs pharmacies up to $426.13 for the same amount.
- "What is your cash price, without insurance?" For low-cost generics it can be less than a copay.
- "Is a 90-day supply cheaper per tablet?" Dispensing fees are charged per fill, so fewer fills often cost less.
- "Do you match other pharmacies or accept discount cards?" Many do, if you ask.
These are questions, not advice. Never change how you take a medicine without talking to your prescriber or pharmacist.
Other lamotrigine strengths and forms
| Strength and form | Per unit | Pharmacies pay | ||
|---|---|---|---|---|
| 50 mg (24 hr) extended-release tablet | $0.5513 | $16.54 / 30 tablets | ||
| 100 mg (24 hr) extended-release tablet | $0.6671 | $20.01 / 30 tablets | ||
| 200 mg (24 hr) extended-release tablet | $0.6485 | $19.45 / 30 tablets | ||
| 250 mg (24 hr) extended-release tablet | $1.21 | $36.44 / 30 tablets | ||
| 300 mg (24 hr) extended-release tablet | $1.28 | $38.29 / 30 tablets | ||
| 25 mg orally disintegrating tablet | $1.28 | $38.39 / 30 tablets | ||
| 50 mg orally disintegrating tablet | $1.33 | $39.75 / 30 tablets | ||
| 100 mg orally disintegrating tablet | $1.59 | $47.69 / 30 tablets | ||
| 200 mg orally disintegrating tablet | $1.79 | $53.56 / 30 tablets | ||
| Pack | Not priced this week | |||
| Pack | $9.50 | $9.50 / 1 kit | ||
| 25 mg tablet | $0.0270 | $0.81 / 30 tablets | ||
| 100 mg tablet | $0.0483 | $1.45 / 30 tablets | ||
| 150 mg tablet | $0.0688 | $2.06 / 30 tablets | ||
| 200 mg tablet | $0.0801 | $2.40 / 30 tablets | ||
| 5 mg tablet for oral suspension | $0.1530 | $4.59 / 30 tablets | ||
| 25 mg tablet for oral suspension | $0.1503 | $4.51 / 30 tablets | ||
Official label & what changed
These highlights do not include all the information needed to use LAMOTRIGINE TABLETS safely and effectively. See full prescribing information for LAMOTRIGINE TABLETS.LAMOTRIGINE Tablets, for oral useInitial U.S. Approval: 1994
WARNING: SERIOUS SKIN RASHES
WARNING: SERIOUS SKIN RASHES
See full prescribing information for complete boxed warning.
Cases of life-threatening serious rashes, including Stevens-Johnson syndrome and toxic epidermal necrolysis, and/or rash-related death have been caused by lamotrigine. The rate of serious rash is greater in pediatric patients than in adults. Additional factors that may increase the risk of rash include:
coadministration with valproate.
exceeding recommended initial dose of lamotrigine.
exceeding recommended dose escalation for lamotrigine.
presence of the HLA-B*1502 allele. (5.1)
Benign rashes are also caused by lamotrigine; however, it is not possible to predict which rashes will prove to be serious or life threatening. Lamotrigine should be discontinued at the first sign of rash, unless the rash is clearly not drug related. (5.1)
Lamotrigine can cause serious rashes requiring hospitalization and discontinuation of treatment. The incidence of these rashes, which have included Stevens-Johnson syndrome, is approximately 0.3% to 0.8% in pediatric patients (aged 2 to 17 years) and 0.08% to 0.3% in adults receiving lamotrigine. One rash-related death was reported in a prospectively followed cohort of 1,983 pediatric patients (aged 2 to 16 years) with epilepsy taking lamotrigine as adjunctive therapy. In worldwide postmarketing experience, rare cases of toxic epidermal necrolysis and/or rash-related death have been reported in adult and pediatric patients, but their numbers are too few to permit a precise estimate of the rate.
In addition to age, factors that may increase the risk of occurrence or the severity of rash caused by lamotrigine include (1) coadministration of lamotrigine with valproate (includes valproic acid and divalproex sodium), (2) exceeding the recommended initial dose of lamotrigine, (3) exceeding the recommended dose escalation for lamotrigine, or (4) the presence of the HLA-B*1502 allele However, cases have occurred in the absence of these factors.
Nearly all cases of life-threatening rashes caused by lamotrigine have occurred within 2 to 8 weeks of treatment initiation. However, isolated cases have occurred after prolonged treatment (e.g., 6 months). Accordingly, duration of therapy cannot be relied upon as means to predict the potential risk heralded by the first appearance of a rash.
Although benign rashes are also caused by lamotrigine, it is not possible to predict reliably which rashes will prove to be serious or life threatening. Accordingly, lamotrigine should ordinarily be discontinued at the first sign of rash, unless the rash is clearly not drug related. Discontinuation of treatment may not prevent a rash from becoming life threatening or permanently disabling or disfiguring [see Warnings and Precautions (5.1)].
Recent major changes (as listed on the label)
Boxed Warning
| 10/2025
|
Dosage and Administration (2.1, 2.2, 2.4)
| 4/2025
|
Warnings and Precautions,
Serious Skin Rashes
| 10/2025
|
Concomitant Use with Estrogen-Containing Products, Including Oral
Contraceptives (5.9)
| 4/2025
|
Sudden Unexplained Death in Epilepsy (5.12) - removal
| 4/2025
|
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Questions about lamotrigine 25 mg (24 hr) extended-release tablet
How much does lamotrigine 25 mg (24 hr) extended-release tablet cost without insurance?
Pharmacies pay about $10.84 for 30 tablets ($0.3615 per tablet) as of November 11, 2026. A fair cash price is about $22.97: that cost plus a 15% margin and a $10.50 dispensing fee. Online cost-plus pharmacies charge around $22.47 including shipping.
Is my price for lamotrigine 25 mg (24 hr) extended-release tablet fair?
Compare it with the fair cash price of $22.97 for 30 tablets. Up to about $28.71 is fair; above $45.94 is high, and worth asking the pharmacy for its cash price or trying another pharmacy. Check your quote.
Is lamotrigine 25 mg (24 hr) extended-release tablet getting more expensive?
Over the last four weeks the price pharmacies pay rose 31.4%. Over a year it fell 12.9%. See the 52-week chart.
What is the brand name of lamotrigine 25 mg (24 hr) extended-release tablet?
Lamictal 25 mg (24 hr) extended-release tablet. The brand has the same active ingredient but costs pharmacies more.
Who makes lamotrigine 25 mg (24 hr) extended-release tablet?
7 companies: Amneal Pharmaceuticals LLC, Camber Pharmaceuticals Inc, Dr.Reddy's Laboratories Limited, NorthStar Rx LLC, Torrent Pharmaceuticals Limited, Zydus Pharmaceuticals USA Inc., Bryant Ranch Prepack. See every package code.
Is lamotrigine in shortage?
Yes - 6 products are listed as short or being discontinued. Details.
Has lamotrigine been recalled?
13 recalls on record. Recalls name specific lots - check yours.
What does "pharmacies pay" mean?
It's the national average price retail pharmacies pay wholesalers and makers to buy the drug, from a weekly government survey of pharmacy invoices. It doesn't include the pharmacy's costs of filling a prescription, which is why the fair price adds a margin and a dispensing fee. How we work it out.
Talk about lamotrigine 25 mg (24 hr) extended-release tablet
No comments yet. Questions, tips, what worked for you - start the conversation.